Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.TheraBiogen launches TheraMax Migraine Relief
TheraMax Migraine Relief nasal spray is specially designed for the migraine headaches. TheraBiogen claims the delivery system will have a direct effect and is absorbed immediately. The new
TheraMax Migraine Relief nasal spray is specially designed for the migraine headaches. TheraBiogen claims the delivery system will have a direct effect and is absorbed immediately. The new
PharmaNet provides clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies. PharmaNet has been conducting clinical studies for oncology products since 1996 and has an
The study is an open-label, dose-escalating trial which is designed to evaluate the safety and immunogenicity of DPX-0907 in patients with advanced stage breast, ovarian or prostate cancer.
GI-4000 and GI-6207 vaccines are used to target mutated versions of the Ras oncoprotein and CEA expressing tumors respectively. In the first study, GI-4000, a series of Tarmogen
The patent recognizes the company’s intellectual property rights to the composition of matter and methods of use for setrobuvir and related compounds. Setrobuvir, which has received fast track
Under the agreement, PeptLab will continue to provide support in technical inputs for developing Biotage related products. Additionally, PeptLab will also offer training facilities for demonstrating Biotage’s range
The company is organizing a multi-center Phase 3 trial investigating asimadoline in D-IBS, conducted under a Special Protocol Assessment agreement with the FDA for US registration. Tioga Pharma
RBM’s protein detection platform offers pharmaceutical companies with critical information for accelerating drug development research and improve clinical trial outcomes. The company’s proprietary Multi Analyte Profiling (MAP) technology
Completion of the study enables Fero Industries to move forward with plans for registration, licensing and distribution of Sucanon across the Middle East. The pre-clinical and clinical studies
The trial which is sponsored by the National Institutes of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH), expects to recruit around